diaDexus Price Target Increased to $2.90 by Analysts at Feltl & Co. (DDXS)
Equities researchers at Feltl & Co. upped their target price on shares of diaDexus (NASDAQ:DDXS) from $2.15 to $2.90 in a research report issued on Wednesday, Analyst Ratings Net reports. The firm currently has a “strong-buy” rating on the stock. Feltl & Co.’s price target would suggest a potential upside of 43.56% from the stock’s previous close.
Separately, analysts at Maxim Group initiated coverage on shares of diaDexus in a research note to investors on Friday, October 11th. They set a “buy” rating and a $3.00 price target on the stock.
diaDexus (NASDAQ:DDXS) traded up 3.47% on Wednesday, hitting $2.09. 147,939 shares of the company’s stock traded hands. diaDexus has a 52-week low of $0.28 and a 52-week high of $1.54. The stock has a 50-day moving average of $1.33 and a 200-day moving average of $0.85. The company’s market cap is $113.3 million.
diaDexus, Inc (NASDAQ:DDXS) is a medical diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.